Idelalisib-Rituximab induces clinical remissions in patients with TP53 disrupted B cell prolymphocytic leukaemia

被引：8
作者：
Eyre, Toby A. [1 ]
Fox, Christopher P. [2 ]
Shankara, Paneesha [3 ]
Went, Richard [4 ]
Schuh, Anna H. [1 ,5 ,6 ,7 ]
机构：
[1] Oxford Univ Hosp NHS Trust, Churchill Hosp, Dept Haematol, Oxford, England
[2] Nottingham Univ Hosp NHS Trust, Dept Clin Haematol, City Campus, Nottingham, England
[3] Birmingham Heartlands Hosp, Dept Haematol & Stem Cell Transplantat, Birmingham, W Midlands, England
[4] Rotherham NHS Fdn Trust, Dept Clin Haematol, Rotherham, S Yorkshire, England
[5] Oxford Univ Hosp NHS Trust, NIHR BRC Oxford Mol Diagnost Ctr, Oxford, England
[6] Univ Oxford, Dept Oncol, John Radcliffe Hosp, Oxford, England
[7] Univ Oxford, Dept Oncol, Oxford, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2017年 / 177卷 / 03期
关键词：
idelalisib; TP53; deletion; B-cell prolymphocytic leukaemia; prolymphocytic leukaemia; CHRONIC LYMPHOCYTIC-LEUKEMIA; RECEPTOR;
D O I：
10.1111/bjh.14066
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：486 / 491
页数：6
相关论文
共 10 条
  • [1] Survival of leukemic B cells promoted by engagement of the antigen receptor
    Bernal, A
    Pastore, RD
    Asgary, Z
    Keller, SA
    Cesarman, E
    Liou, HC
    Schattner, EJ
    [J]. BLOOD, 2001, 98 (10) : 3050 - 3057
  • [2] Allogeneic peripheral stem-cell transplantation with reduced-intensity conditioning regimen in refractory primary B-cell prolymphocytic leukemia: a long-term follow-up
    Castagna, L
    Sarina, B
    Todisco, E
    Mazza, R
    Santoro, A
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 (12) : 1225 - 1225
  • [3] Complete response to alemtuzumab in a patient with B prolymphocytic leukemia
    Chaar, Bassem T.
    Petruska, Paul J.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (05) : 417 - 417
  • [4] How I treat prolymphocytic leukemia
    Dearden, Claire
    [J]. BLOOD, 2012, 120 (03) : 538 - 551
  • [5] PENTOSTATIN IN PROLYMPHOCYTIC LEUKEMIA - PHASE-II TRIAL OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER LEUKEMIA COOPERATIVE STUDY-GROUP
    DOHNER, H
    HO, AD
    THALER, J
    STRYCKMANS, P
    SONNEVELD, P
    DEWITTE, T
    LECHNER, K
    LAURIA, F
    BODEWADTRADZUN, S
    SUCIU, S
    SOLBU, G
    WITT, B
    HUNSTEIN, W
    ZITTOUN, R
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (08) : 658 - 662
  • [6] Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
    Furman, Richard R.
    Sharman, Jeff P.
    Coutre, Steven E.
    Cheson, Bruce D.
    Pagel, John M.
    Hillmen, Peter
    Barrientos, Jacqueline C.
    Zelenetz, Andrew D.
    Kipps, Thomas J.
    Flinn, Ian
    Ghia, Paolo
    Eradat, Herbert
    Ervin, Thomas
    Lamanna, Nicole
    Coiffier, Bertrand
    Pettitt, Andrew R.
    Ma, Shuo
    Stilgenbauer, Stephan
    Cramer, Paula
    Aiello, Maria
    Johnson, Dave M.
    Miller, Langdon L.
    Li, Daniel
    Jahn, Thomas M.
    Dansey, Roger D.
    Hallek, Michael
    O'Brien, Susan M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (11) : 997 - 1007
  • [7] The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
    Herishanu, Yair
    Perez-Galan, Patricia
    Liu, Delong
    Biancotto, Angelique
    Pittaluga, Stefania
    Vire, Berengere
    Gibellini, Federica
    Njuguna, Ndegwa
    Lee, Elinor
    Stennett, Lawrence
    Raghavachari, Nalini
    Liu, Poching
    McCoy, J. Philip
    Raffeld, Mark
    Stetler-Stevenson, Maryalice
    Yuan, Constance
    Sherry, Richard
    Arthur, Diane C.
    Maric, Irina
    White, Therese
    Marti, Gerald E.
    Munson, Peter
    Wilson, Wyndham H.
    Wiestner, Adrian
    [J]. BLOOD, 2011, 117 (02) : 563 - 574
  • [8] B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene
    Lens, D
    Coignet, LJA
    Brito-Babapulle, V
    Lima, CSP
    Matutes, E
    Dyer, MJS
    Catovsky, D
    [J]. LEUKEMIA, 1999, 13 (06) : 873 - 876
  • [9] Moreau EJ, 1997, AM J CLIN PATHOL, V108, P378
  • [10] ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia
    Pospisilova, S.
    Gonzalez, D.
    Malcikova, J.
    Trbusek, M.
    Rossi, D.
    Kater, A. P.
    Cymbalista, F.
    Eichhorst, B.
    Hallek, M.
    Doehner, H.
    Hillmen, P.
    van Oers, M.
    Gribben, J.
    Ghia, P.
    Montserrat, E.
    Stilgenbauer, S.
    Zenz, T.
    [J]. LEUKEMIA, 2012, 26 (07) : 1458 - 1461
1